Corcept Therapeutics
Price & Volume
Stats
See moreOpen | $80.50 |
Previous Close | $80 |
Day Range | $79.90-$84.48 |
52W Range | $42.01-$117.33 |
Market Cap | $8.4B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $716M |
Revenue Growth (YoY) | 18.7% |
Gross Profit (12 Mos) | $703.9M |
Diluted EPS | $1.12 |
News
See moreYahoo Finance • 8 days ago
Alger Russell Innovation Index Updates for Third Quarter 2025
Yahoo Finance • 13 days ago
Corcept's ovarian cancer treatment under FDA review
Yahoo Finance • last month
Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT
About
CEO | Dr. Joseph K. Belanoff M.D. |
CFO | Mr. Atabak Mokari |
Address | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 500 |
